Low-dose decitabine versus best supportive care in elderly patients with intermediate- or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final results of the randomized phase III study of the European Organisation fo (Q48693524)
Jump to navigation
Jump to search
scientific article published on 11 April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Low-dose decitabine versus best supportive care in elderly patients with intermediate- or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final results of the randomized phase III study of the European Organisation fo |
scientific article published on 11 April 2011 |
Statements
1 reference
Low-dose decitabine versus best supportive care in elderly patients with intermediate- or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final results of the randomized phase III study of the European Organisation fo (English)
1 reference
Ulrich Germing
1 reference
Carlo Aul
1 reference
Aristoteles Giagounidis
1 reference
Uwe Platzbecker
1 reference
Petra Muus
1 reference
Stefan Suciu
1 reference
Michael Lübbert
1 reference
Liliana Baila
1 reference
Björn Hans Rüter
1 reference
Dominik Selleslag
1 reference
Boris Labar
1 reference
Helmut R Salih
1 reference
Filip Beeldens
1 reference
Karl-Heinz Pflüger
1 reference
Corneel Coens
1 reference
Anne Hagemeijer
1 reference
Hans Eckart Schaefer
1 reference
Arnold Ganser
1 reference
Theo de Witte
1 reference
Pierre W Wijermans
1 reference
11 April 2011
1 reference
29
1 reference
15
1 reference
1987-1996
1 reference